KALARIS THERAPEUTICS, INC. Public Float
KALARIS THERAPEUTICS, INC. (KLRS) had Public Float of $12.60 million as of 2025-06-30, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-17
- 2025-06-30: Entity Public Float $12.60M.
- 2024-06-28: Entity Public Float $58.80M.
- 2023-06-30: Entity Public Float $265.40M.
- 2022-06-30: Entity Public Float $143.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $12.60M 10-K · filed 2026-03-17 |
| 2024-06-28 | $58.80M 10-K · filed 2025-03-07 |
| 2023-06-30 | $265.40M 10-K · filed 2024-03-15 |
| 2022-06-30 | $143.50M 10-K · filed 2023-02-15 |
| 2021-06-30 | $598.90M 10-K/A · filed 2022-03-30 |
| 2021-02-02 | $1.29B 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |